Sign inJoin waitlistJoin the waitlist

Christine Franzese

Allergy Medical Director · University of Missouri-Columbia School of Medicine

Credentials: · · · · ·

History

Otolaryngology - Head and Neck Surgery
University of Mississippi School of Medicine
1999–2004
SUNY Upstate Medical University Coll of Med
1995–1999

Research

International consensus statement on allergy and rhinology: Allergic rhinitis - 2023
Review · International Forum of Allergy & Rhinology · 2023 · 401 citations
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
International Forum of Allergy & Rhinology · 2018 · 399 citations
Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis
American Journal of Rhinology and Allergy · 2022 · Last of 6 authors · 52 citations

CD
Cecelia Damask
6 papers
Sarah Wise
5 papers
Ashleigh Halderman
4 papers
Edward McCoul
4 papers
JL
Joshua Levy
4 papers · 1 as a fellow
Sandra Lin
4 papers
Stella Lee
4 papers
Ahmad Sedaghat
3 papers
Amber Luong
3 papers
Edward Kuan
3 papers
Elina Toskala
3 papers · 3 as a resident
Katie Phillips
3 papers · 3 as a resident

Clinical trials

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Site PI · Recruiting · Phase 3
Optinose US Inc.
2025–2028
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2027
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2024–2028